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Rabies  virus  (RABV)  is enzootic  throughout  most  of  the world.  It is now  widely  accepted  that  RABV  had  its
origins  in  bats.  Ten  of  the  11  Lyssavirus  species  recognised,  including  RABV,  have  been  isolated  from  bats.
There  is,  however,  a lack  of  understanding  regarding  both  the ecology  and  host reservoirs  of  Lyssaviruses.
A  real-time  PCR  assay  for the  detection  of  all  Lyssaviruses  using  universal  primers  would  be beneﬁcial
for  Lyssavirus  surveillance.  It was  shown  that  using  SYBR® Green,  a universal  real-time  PCR  primer  pair
previously  demonstrated  to  detect  European  bat Lyssaviruses  1  and  2, and  RABV,  was  able  to  detect  reverseyssavirus
abies
at
YBR Green
eal-time PCR
ynthetic DNA
transcribed  RNA  for each  of  the  seven  virus  species  available  to  us.  Target  sequences  of  bat  derived  virus
species  unavailable  for analysis  were  synthesized  to  produce  oligonucleotides.  Lagos  Bat-,  Duvenhage-
and  Mokola  virus  full  nucleoprotein  gene  clones  enabled  a limit  of 5–50 plasmid  copies  to be  detected.
Five  copies  of  each  of the  synthetic  DNA  oligonucleotides  of Aravan-,  Khujand-,  Irkut-,  West  Caucasian  bat-
and  Shimoni  bat  virus  were  detected.  The  single  universal  primer  pair  was  therefore  able to detect  each
of the  most  divergent  known  Lyssaviruses  with  great  sensitivity.
© 2011 Elsevier B.V. Open access under CC BY license.. Introduction
Rabies virus (RABV), genus Lyssavirus,  family Rhabdoviridae,  is
nzootic throughout most of the world. The domestic dog (Canis
amiliaris) acts as the principal vector (Knobel et al., 2005, 2007),
owever, a range of mammalian carnivores also can act as hosts
Childs and Real, 2007; Davis et al., 2007; Hass and Dragoo, 2006;
el et al., 1993; Real et al., 2005; Rupprecht et al., 1995; Swanepoel
t al., 1993; Velasco-Villa et al., 2005; von Teichman et al., 1995).
abies remains the only disease considered to have a 100% mor-
ality rate and millions of animals are killed each year from both
he disease and control programmes (Knobel et al., 2005). It is now
idely accepted that RABV had its origins in bats and, with the
xception of Mokola virus (MOKV), all known Lyssaviruses have
een isolated from bats (Badrane and Tordo, 2001; Kuzmin et al.,
003, 2005, 2010).
∗ Corresponding author at: Cambridge Infectious Diseases Consortium, Depart-
ent of Veterinary Medicine, University of Cambridge, Madingley Road, Cambridge
B3  0ES, UK. Tel.: +44 1223765636.
E-mail address: dtsh2@cam.ac.uk (D.T.S. Hayman).
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Open access under CC BY license.The Lyssavirus genus can be differentiated into 11 geneti-
cally divergent species based on genetic analyses of the viral
genome (ICTV, 2009; Kuzmin et al., 2005). The species are: Rabies
virus (RABV; Lagos bat virus (LBV); Mokola virus (MOKV); Duven-
hage virus (DUVV); European bat Lyssavirus-1 (EBLV-1); European
bat Lyssavirus-2 (EBLV-2), Australian bat Lyssavirus (ABLV), Irkut
virus (IRKV), Aravan virus (ARAV), Khujand virus (KHUV) and West
Caucasian bat virus (WCBV) (ICTV, 2009). A twelfth genetically
related virus, Shimoni bat virus (SHIBV) is yet to be classiﬁed, but
may  become recognised as a new species (Kuzmin et al., 2010).
SHIBV shares approximately 80% nucleotide identity with other
Lyssaviruses. Recent studies have also shown LBV phylogeny to be
more complex than ﬁrst thought and four distinct LBV lineages are
now reported with high levels of sequence divergence amongst
them (Delmas et al., 2008; Kuzmin et al., 2010; Markotter et al.,
2008).
The Lyssaviruses can further be grouped into phylogroups
according to relative antigenicity and sequence diversity (Badrane
et al., 2001). Phylogroup I includes all known species apart
from LBV, SHIBV, MOKV and WCBV. Along with DUVV, the phy-
logroup II viruses, LBV, MOKV and SHIBV, have solely African
distributions. WCBV awaits classiﬁcation with regards to phy-
logroup, but has been proposed as a new phylogroup (III) (Hanlon
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Table 1
Lyssaviruses used in this study.
Isolate laboratory
reference
Isolate GenBank
reference
Country of origin Animal of origin (latin names are
given for wildlife, and all are bats
except where stated)
Year of isolation Lyssavirus species
and reference
name
RV1 U22842 Nigeria Eidolon helvum 1956 LBV (b); LBVNig56
RV2 AY062072 South Africa Epomophorus wahlbergi 1980s LBV (c)
RV3  AY062073 South Africa Epomophorus wahlbergi 1980s LBV (c)
RV4  AY062074 Nigeria Shrew (Crocidura spp) 1968 MOKV
RV5  AY062077 South Africa Domestic cat 1970 MOKV
RV20 AY062085 Denmark Eptesicus serotinus 1986 EBLV 1
RV39 AY062075 Cameroon Shrew (Crocidura spp) 1974 MOKV
RV40 AY062076 Central African
Republic
Lophuromys sikapusi (rodent) 1983 MOKV
RV41  AY339890 Senegal Eidolon helvum 1985 LBV (a), LBVSen85
RV42  EU293117 Cameroon Shrew (Crocidura spp) 1974 MOKV
RV43 EF547449 Central African
Republic
Micropteropus pussilus 1974 LBV (c), LBVCAR74
RV131 AY062080 Zimbabwe Nycteris thebaica 1986 DUVV, DUVV86
RV133  EF547450 Zimbabwe Domestic cat 1986 LBV (c), LBVZim86
RV134 EF547455 South Africa Domestic cat 1982 LBV (c), LBVSA82
RV139 AY062081 South Africa Bat (possibly Miniopterus
natalensisa)
1981 DUVV
RV175 FJ465418 Zimbabwe Domestic cat 1981 MOKV
RV611 AY33110 Ethiopia Domestic dog 1982 LBV (c), LBVEth89
RV628 U89478 UK Myotis daubentonii 1996 EBLV 2
RV634  AF006497 Australia Pteropus alecto 1996 ABLV
RV767 EF547449 France (originally
Egypt or Togo)
Rousettus aegyptiacus 1999 LBV (a), LBVFra99
RV994 JN016749 South Africa Domestic dog 2000 RABV
RV1021 FJ465414 South Africa Domestic cat 1996 MOKV
NA  EF61426 Tajikistan Myotis daubentoni 2001 KHUV
NA EF614260 Russia Murina leucogaster 2002 IRKV
NA  EF614259 Kyrgyzstan Myotis blythi 1991 ARAV
NA EF614258 Russia Miniopterus schreibersi 2002 WCBV
NA  GI291195467 Kenya Hipposideros commersoni 2009 SHIBV
a Previously this was described as Miniopterus schreibersii, however the genus has been reclassiﬁed with the African species now named M.  natalensis.
e
v
t
s
2
r
w
A
t
W
o
(
i
g
V
e
A
s
i
i
V
a
e
t
w
2
d
p
ct al., 2005; Kuzmin et al., 2005). It is important to note that
accines derived from RABV strains confer little or no protec-
ion against members of phylogroups II and III in experimental
tudies (Badrane et al., 2001; Brookes et al., 2006; Hanlon et al.,
001, 2005; Weyer et al., 2008).
In order to understand virus diversity, ecology and virus-host
elationships in bats and other mammalian orders, molecular tools
hich are able to detect each of the Lyssaviruses are required. In the
mericas, for example, only RABV circulates; however elsewhere
he situation is less clear. For example EBLV-1 (phylogroup I) and
CBV (putative phylogroup III) have been isolated from (WCBV),
r nucleic acids detected in (EBLV-1) bats of the genus Miniopterus
Banyard et al., 2011). In addition, a member of this genus has been
mplicated in DUVV transmission in Africa (Sabeta et al., 2007). This
enus of bat occurs throughout much of Africa, as well as Eurasia.
irus isolations for these Lyssaviruses have been made on differ-
nt continents with LBV and DUVV being isolated from bats in
frica, and WCBV from a bat in the Caucasus in Russia. Subsequent
tudies, however, detected anti-WCBV virus neutralising antibod-
es (VNAs) in Miniopterus bats in Africa, suggesting that this virus
nfects bats over a broad geographical area (Kuzmin et al., 2008b).
iruses belonging to phylogroups I and II (LBV and DUVV) have
lso been isolated from African bats of the Nycteris genus (King
t al., 1994; Kuzmin, 2008; Kuzmin et al., 2005). It is noteworthy
hat sera containing VNAs are often able to cross-neutralise viruses
ithin the same phylogroup (Brookes et al., 2005; Wright et al.,
010). Both anti-LBV and anti-MOKV VNAs, for example, have been
etected in E. helvum in which LBV is thought to circulate. Although
robably representing cross neutralisation by LBV positive sera,
o-infection with MOKV or the discovery of other phylogroup IIviruses, such as SHIBV, cannot be ruled out in these populations
and broadly sensitive assays are required for surveillance stud-
ies (Dzikwi et al., 2010; Kuzmin et al., 2008a, 2010; Wright et al.,
2010).
Previously, several real-time reverse transcription RT-qPCR
assays for the detection of RABV have been described, including
a TaqMan® assay for the detection and discrimination of RABV
from EBLV-1 and EBLV-2, and an assay designed to detect, but
not discriminate amongst, DUVV, RABV, LBV and MOKV (Coertse
et al., 2010; Hoffmann et al., 2010; Wakeley et al., 2005). These
assays have been shown to be more sensitive than conven-
tional nested or hemi-nested RT-PCR. These assays, however,
require numerous cocktails of primers and TaqMan® probes, or
else have only been used to detect speciﬁc target species. We
therefore wished to design a real-time assay that could detect
each of the Lyssaviruses, in order to enable researchers to use
this assay for surveillance studies where the Lyssavirus species
present is unknown, or there may  be numerous viruses circulating
in putative reservoir hosts. We  therefore describe the develop-
ment of a SYBR® Green (Applied Biosystems, Foster City, CA,
USA) application using two  pre-existing PCR primers (JW12 and
N165-146), which have been validated to detect RABV, EBLV-1
and -2 (Wakeley et al., 2005), to develop a rapid and sensitive
real time assay for the detection of all Lyssaviruses. These primers
target the nucleoprotein (N) gene, which is the most abundant
transcript generated during infection and which includes areas
that remain highly conserved across the species. For those newly
described Lyssaviruses that were not available for analysis from
infected material, viral cDNAs were synthesized to determine if
they could be detected using the JW12 and N165-146 primers.
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e demonstrate that these universal primers are able to tar-
et the complementary genome of each of the known Lyssavirus
pecies.
. Materials and methods
.1. RNA samples
To compare the sensitivity of different PCR assays, total RNAs
ere extracted from experimentally infected mouse brain tissues
rom the Veterinary Laboratories Agency (VLA) archive (Table 1).
xtractions were performed using TRIZOLTM (InvitrogenTM, Pais-
ey, United Kingdom) and RNA was resuspended in DEPC-treated
ater to 1 g/l. LBV isolates extracted included three suggested
BV lineages (A, B, C) (Markotter et al., 2009).
.2. Reverse transcription
Ten-fold dilution series (1–1 × 10−8g/l)  of total RNA of each
ample were made in nuclease-free water. Total RNA (2 L) was
everse transcribed using Moloney murine leukemia virus reverse
ranscriptase (MMLV-RT) and the primer JW12, at 42 ◦C for 60 min,
s published previously (Heaton et al., 1997; Wakeley et al., 2005).
he cDNA was diluted 1:10 in nuclease-free water.
.3. Hemi-nested PCR
Complementary DNA samples were analysed using a hemi-
ested (hn) PCR incorporating pan-Lyssavirus primers (JW6/12,
W10/12) (Heaton et al., 1997) for comparative limit of detection
urposes and sequencing. Note that the JW12 primer is identical in
oth this and the real-time assay.
.4. Sequencing
Hemi-nested PCR products derived from a selection of sam-
les were sequenced to ensure that the cDNA used in both hn-
nd qPCR were the correct viruses and shared the phylogenetic
elationships with those previously described (Markotter et al.,
008). All RT-qPCR tests were performed using the same cDNA as
hat used for the hnRT-PCR from which the sequence data were
erived. Direct consensus DNA sequencing of a 405 bp region of
he N gene was undertaken as previously described (Johnson et al.,
003). Sequences produced were edited using SeqMan (DNASTAR
asergene®, Madison, WI,  USA) and aligned (ClustalW, Megalign,
NASTAR Lasergene®, Madison, WI,  USA).
.5. SYBR® Green qPCR
Real-time PCR methods using JW12 and N165-146 primers pre-
iously described (Wakeley et al., 2005) were adapted for use using
he dsDNA dye SYBR® Green (Applied Biosystems, Foster City, CA,
SA). The primers were designed against all the Lyssavirus species
vailable at the time of the original study (n = 7 species) using N
ene sequences from 557 viruses (Wakeley et al., 2005). Primer
equences and locations used in this study are given in Table 2.
Consensus sequences for the N gene were generated for all
yssavirus species using MegAlign (DNASTAR Lasergene®, Madi-
on, WI,  USA). The consensus sequences were then compared by
sing the same software to ensure the universal primers JW12 and
165-146 would anneal to each Lyssavirus species (Fig. 1).
SYBR® Green Hot Start (Applied Biosystems, Foster City, CA,SA) PCRs were performed using 20 L SYBR® Green Hot Start,
3 L nuclease-free water, 1 L JW12 (20 pmol/L) primer, 1 L
165-146 (20 pmol/L) primer, and 5 L cDNA. Ampliﬁcation was
ccording to the following heating and cooling program: 1 cycle ofical Methods 177 (2011) 87– 93 89
94 ◦C for 2 min  followed by 40 cycles of 94 ◦C for 30 s, 55 ◦C for 30 s,
and 72 ◦C for 30 s, followed by one cycle each of 95 ◦C for 1 min,
55 ◦C for 30 s, and 72 ◦C for 30 s. The reactions were carried out in
Thermo-Fast 96-well PCR plates or Thermo-tube strips with Ultra
Clear caps (ABgene®, Thermo Scientiﬁc, Epsom, United Kingdom)
in an MX3000P multiplex quantitative PCR system (Stratagene, La
Jolla, CA, USA). For each RT-PCR, a critical threshold cycle num-
ber (CT) was determined corresponding to the PCR cycle number at
which the ﬂuorescence of the reaction exceeded a value determined
to be statistically higher than the background by the software asso-
ciated with the MX3000P system (Stratagene, La Jolla, CA, USA). In
addition, melting curve analyses and gel electrophoresis were per-
formed to ensure false positive results, such as those due to primer
dimers, were not included in any results. Negative controls were
included for each row of samples. A single RABV control (CVS-11,
GenBank AB069973) was  included in each run with samples of virus
isolation origin, but not with those using plasmids.
2.6. Sensitivity analysis
Limit of detection analyses were performed from the same cDNA
for both the qPCR using JW12 and N165-146 and the previously
published hn-PCR.
For those viruses not included in previous studies (Wakeley
et al., 2005), real-time PCR sensitivity was also determined by pro-
ducing full-length N gene blunt ended PCR products and inserting
these into a pCR®-Blunt II-TOPO® plasmid vector (InvitrogenTM,
Paisley, United Kingdom) to produce standard controls and tem-
plates for in vitro transcription of RNA using the MEGAScript kit
(Ambion®, Foster City, CA, USA). For species which viruses them-
selves were unavailable, cDNA sequences from GenBank were
synthesised (see below).
To produce the N gene clones, total RNA was  isolated as
described above from cell-cultured isolates of MOKV (RV4), DUVV
(RV131) and three suggested LBV lineages (A, RV41; B, RV1; and
C, RV3). RNA was reverse transcribed using SuperScript IIITM First-
Strand Synthesis System for RT-PCR (InvitrogenTM, Paisley, United
Kingdom) and random hexanucleotide primers. Lineage speciﬁc
reverse primers and JW12 (Table 2) were used to produce blunt
ended PCR products, which were puriﬁed and cloned using the
Zero Blunt® TOPO® PCR Cloning kit (InvitrogenTM, Paisley, United
Kingdom). Plasmids were analysed using M13  primer PCR to check
for appropriate orientation and that the correct gene termini were
present.
Plasmid DNA template was linearised using either Hinc II or
KpnI restriction enzyme (Promega Corporation, Madison, WI,  USA).
Digests were terminated and in vitro transcription performed
(MEGAscript®, Ambion®, Foster City, CA, USA) using T7 or SP6
promotor primers, depending on the inserted nucleoprotein ori-
entation, to synthesize RNA. DNase (MEGAscript Kit®, Ambion®,
Foster City, CA, USA) was  added for a 15 min  incubation at 37 ◦C
to remove the DNA template. RNA was recovered using Lithium
chloride precipitation. Hemi-nested PCRs were performed as above
with and without reverse-transcription, to ensure no DNA  was
contaminating the RNA and DNase treatment was  repeated as
necessary. The RNA yield was quantiﬁed by UV light absorbance
(NanoDrop Spectrophotometer, Thermo Scientiﬁc, Epsom, United
Kingdom) and serial dilutions were made of each lineage RNA and
plasmid. The comparative sensitivity of the SYBR® Green (Applied
Biosystems, Foster City, CA, USA) was studied using the serial dilu-
tions. For all sensitivity analyses, the DNA or RNA copy numbers
detected was  deduced from the amount of DNA or RNA added to
the PCR, the molecular weight of the nucleic acids and Avogadro’s
number.
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Table 2
Primers used for the qRT-PCR sensitivity study. Primers for the production of full length nucleocapsid gene amplicons for cloning during this study, and primers used in the
real-time  PCR assays, are described, where R, purine (A/G); Y, pyrimidine (C/T).
Primer Sequence Sense Position Reference genome
JW12 5′ATGTAACACCYCTACAATG3′ M 55–73 M13215 (Pasteur virus)
LBV  N Nig Rev 5′TTATGAGCTCTCTGAATACAC3′ G 1332–1353 U22842
LBV  N Sen Rev 5′TCAAGAGCTCTCCGAGTACAC3′ G 1332–1353 AY339890
LBV  N SA Rev 5′CTATGAGCTCTCCGAATACAC3′ G 1332–1353 AY062072
′ ′
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(DUVV  N Rev 5 GGATGAGGTCACTGAGGTCTATT3
MOKV  N Rev 5′CAGATACGGCTACCTAGTATT3′
N165  -146 5′GCAGGGTAYTTRTACTCATA3′
.7. Synthetic DNA
The 40–180 base region of each of the bat derived viruses
navailable but published in GenBank were aligned with JW12 and
165-146 (Fig. 1) and 20 nmole Ultramer DNA oligonucleotides
ere synthesized (Integrated DNA Technologies, Coralville, IA,
SA). A T7 promoter region for RNA transcription and an ATCGATCG
eader in the 5′-3′ direction were included to allow efﬁcient primer
inding and for future studies. Ultramer DNA was serially diluted
0-fold in RNase free water and SYBR® Green (Applied Biosystems,
oster City, CA, USA) PCR with JW12 and N165-146 primers per-
ormed as above.
. Results
Viral nucleic acids from each of the Lyssaviruses available were
etected by the universal primers using a SYBR® Green (Applied
iosystems, Foster City, CA, USA) qPCR assay when RNA was
xtracted from infected material (Table 3). The qPCR products pro-
uced were detectable by both SYBR® Green (Applied Biosystems,
oster City, CA, USA) and gel electrophoresis (data not shown).
emi-nested PCR products from RABV, LBV, MOKV, DUVV, EBLV-
ig. 1. Alignment of all Lyssavirus species to date with JW12 forward and N165-146 rev
ptimal alignment. Primer region is underlined for clarity. Nucleoprotein start sequence i
s  follows: RABV is PV (NC001542), LBV (a) is 0406SEN (EU293108), LBV (b) is 8619NGA
UVV  is 94286SA (EU293120), EBLV1 is RV9 (EF614261), EBLV-2 is RV1333 (EF157977),
EF614258) and SHIBV (GU170201). *Please note: genome sequence was  not available forG 1332–1353 AY062081
G 1332–1353 AY062074
G 165–146 M13215 (Pasteur virus)
1, EBLV-2 and ABLV have all previously been successfully reverse
transcribed, ampliﬁed, and 405 bp regions of the N-gene sequenced
using the hnRT-PCR. In this study, this was  extended to include
viruses from each of the three suggested LBV lineages (A, B and C).
The comparative sensitivity of a qPCR assay using this primer
pair has already been assessed for RABV, EBLV-1 and -2. There-
fore, in this study the comparative sensitivity of the primer pair
was assessed against the hnRT-PCR assay using SYBR® Green using
serial dilutions of LBV lineages A, B and C, DUVV and MOKV from
archived material. The SYBR® Green (Applied Biosystems, Foster
City, CA, USA) PCR assay was  typically shown to be approximately
200-fold more sensitive than the previously published hnRT-PCR,
depending on Lyssavirus species and lineage (Table 3), a similarly
greater sensitivity to that for the RABV, EBLV-1 and -2 qPCR assay
using the same primers (Wakeley et al., 2005).
LBV, DUVV and MOKV full N gene sequences were successfully
cloned into a pCR®-Blunt II-TOPO® plasmid vector with matching
consensus sequence for the virus used. Using the species speciﬁc N
gene clones as templates the limit of detection for the SYBR® Green
(Applied Biosystems, Foster City, CA, USA) PCR assay was  calculated.
This was shown to be 5–50 plasmid copies. An approximate 28-fold
sensitivity was lost during the RT step (Table 3).
erse primer. Dots represent identity to consensus sequence, hyphens are gaps for
s in bold. Position 1 is the start of the genome. Sequences used in this alignment are
 (EU293110), LBV (c)* is LBVSA1980 (EF547457), MOKV is 86101RCA (EU293118),
 ABLV (AF418014), ARAV (EF614259), IRKV (EF614260), KHUV (EF614261), WCBV
 this sub-species, therefore full N was used instead.
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Table  3
PCR assay sensitivity for a range of Lyssaviruses tested during this study. RNA was extracted from infected material for the ‘limit of detection’ studies, serially diluted and
used  to generate cDNA. The same cDNA sample was  used for both the hemi-nested PCR and SYBR® Green PCR with the limit of detection dilutions of initial total RNA given
for  comparison. Nucleoprotein gene plasmid copies or synthetic Ultramer DNA oligonucleotide copy detection limit and RNA generated by in vitro transcription (IVT) copy
numbers from these plasmids are also given. Not tested is shown by “–”, not available by “NA”.
Isolate reference Lyssavirus
species
Limit of detection
by hemi-nested
RT-PCR (initial
g/L total RNA
used)
Hemi-nested
product sequenced
Limit of detection
by SYBR® Green
PCR (initial g/L
total RNA used)
Plasmid or synthetic
Ultramer DNA
oligonucleotide copies
detected by SYBR®
Green PCR
IVT  derived cDNA
copies detected by
SYBR® Green PCR
RV1 LBV (b) 10−2 Yes 10−4 50 195
RV2  LBV (c) 10−2 Yes 10−8 – –
RV3 LBV  (c) 10−1 Yes 10−5 5 –
RV4  MOKV 10−5 Yes 10−6 5 1430
RV5  MOKV 10−5 Yes 10−5 – –
RV20  EBLV 1 – – 10−6 – –
RV39 MOKV 10−5 Yes 10−6 – –
RV40  MOKV 10−5 Yes 10−6 – –
RV41 LBV (a) 10−4 Yes 10−5 5 25
RV42  MOKV 10−5 Yes 10−6 – –
RV43 LBV (c) 10−3 Yes 10−7 – –
RV131  DUVV 10−1 Yes 10−3 5 190
RV133 LBV (c) 10−3 Yes 10−5 – –
RV134  LBV (c) 10−4 Yes 10−5 – –
RV139  DUVV 1 Yes 10−2 – –
RV175 MOKV – – 10−7 – –
RV611  LBV (c) 1 Yes 10−2 – –
RV628 EBLV 2 – – 10−6 – –
RV634  ABLV – – 10−6 – –
RV767  LBV (a) 10−3 Yes 10−6 – –
RV994  RABV – – 10−7 – –
RV1021  MOKV – – 10−7 – –
NA KHUV – – – 5 –
NA  IRKV – – – 5 –
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tNA ARAV – – 
NA  WCBV – – 
NA  SHIBV – – 
Lyssaviruses isolated on single occasions from Eurasian bats
nd, in SHIBV’s case, an African bat, were not available for test-
ng in this study. However, sequence alignment in silico suggested
hat the primer set JW12 and N165-146 would successfully prime
ff all virus nucleic acids analysed (Kuzmin et al., 2005) (Fig. 1).
o test this, DNA was synthesized commercially using published
equences and serially diluted in 10-fold dilutions and DNA was
etected to a lower limit of 5 copies for each virus.
. Discussion
The SYBR® Green qPCR assay in this study has been developed
o demonstrate that the universal primer pair, JW12 and N165-146
argets the N gene successfully for each of the known Lyssavirus
pecies. We  developed this to address the problems associated
ith the diagnosis of divergent Lyssavirus infections. There are cur-
ently numerous assays available for rabies and Lyssavirus detection
nd these have recently been reviewed (Fooks et al., 2009). Of
he several real-time PCR assays published, however, none has
een validated against for the detection of all published Lyssavirus
pecies. Despite the need for further assessment of the sensitiv-
ty of this assay, including as a possible one-step technique, we
ave demonstrated that this primer pair in a real-time application
s more sensitive for the detection of all Lyssavirus cDNA that we
ested, when compared with a known pan-Lyssavirus hnRT-PCR.
or some genetically similar viruses, e.g. RV2 and RV611 from LBV
ineage C, there appeared to be substantial differences in limits of
etection by qPCR. Whilst standardising for total RNA, the true
uantity of virus RNA is unknown in these samples. Using plas-
id  clones addresses this somewhat (see below), however, the
ubstantial differences in detection between the qPCR and hnRT-
CR for LBV lineage C viruses may  reﬂect poor primer binding of
he hnRT-PCR for LBV viruses RV2 and RV3, compared to the qPCR– 5 –
– 5 –
– 5 –
primer pair. This has been discussed previously by another group
(Coertse et al., 2010). Further evidence of the increased primer
binding efﬁciency for this universal primer pair has been previ-
ously demonstrated on a panel of over 40 RABV and a range of
EBLV-1 and -2 viruses (Wakeley et al., 2005), which demonstrated
a similarly greater sensitivity over the hnRT-PCR to that found in
this study. This new assay overcomes restrictions in the current
hnRT-PCR assay which requires multiple transfers of material and
substantial time (both in required man-hours for preparation and
thermal cycling) (Heaton et al., 1997). Despite this, the hnRT-PCR
has been sufﬁcient to detect virus from each virus-positive brain
sample and therefore still offers a useful tool for rabies diagnosis
where conventional PCR technology exists. Importantly, hnRT-PCR
produces a PCR product that is readily sequenced.
The use of only two universal primers (JW12 and N165-146)
plus SYBR® Green (Applied Biosystems, Foster City, CA, USA) dsDNA
dye is an easy to use assay which enabled each of the viruses
archived in the WHO  and OIE rabies reference laboratory at VLA
to be detected in infected brain material. The PCR assay was  shown
to be highly sensitive, detecting between 5 and 50 copies of N-gene
target sequences when cDNA from MOKV, DUVV and LBV (lineage
A, B and C) were cloned into plasmid vectors and 25–195 copies of
LBV RNA generated by in vitro transcription. Sensitivity for MOKV
and DUVV RNA was  lower, with 190–1430 copies detected. In each
case, when used on infected material, the assay was more sensitive
than the previously published hnRT-PCR, however future studies
should assess the RNA detection limit for each of the viruses known.
Additional attempts to further optimise the RT step, which leads to
a loss of sensitivity, should also be made.The use of synthetic DNA for the Lyssaviruses isolated on
single occasions from bats is novel and demonstrates that this
JW12/N165-146 primer pair is able to detect cDNA from all cur-
rently known species. The detection limit was good; with the
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W12/N165-146 SYBR® Green assay able to detect 5 DNA copies
f DNA Ultramers. This JW12/N165-146 primer set has previously
een described for use with RABV, EBLV-1 and EBLV-2 TaqMan®
robes (Wakeley et al., 2005) and in this study was  shown to
etect ABLV cDNA when used in conjunction with the dsDNA dye,
YBR® Green (Applied Biosystems, Foster City, CA, USA). This assay,
herefore, has the potential to be expanded to incorporate an RT
tep to make this assay a single tube test. Further testing, how-
ver, will be required to validate this assay for use as an OIE/WHO
rescribed test, and it is likely that additional advances in tech-
ology will be required if the ultimate aim of having a sensitive
iagnostic assay which differentiates between viruses is achieved
Fooks et al., 2009). Despite the lack of ability of the SYBR® Green
Applied Biosystems, Foster City, CA, USA) assay to differentiate
pecies, the simplicity of this assay makes this an attractive option
or laboratory use as a screening surveillance tool, enabling further
nalysis by hnRT-PCR or examination of the real-time PCR product
y cloning and sequencing.
The current WHO  “gold standard” test is the ﬂuorescent anti-
ody test (FAT), which uses a conjugated monoclonal antibody
gainst the RABV nucleoprotein, but is believed to detect all viruses.
eveloping a sensitive real-time PCR assay capable of detecting all
at and phylogroup II Lyssaviruses is particularly important, given
hat there is a considerable lack of understanding regarding the
cology of most bat Lyssaviruses and that of MOKV. Indeed, the
eservoir of MOKV is still unknown, despite it being a zoonotic
nfection leading to human deaths. The assay described should
llow the detection of low levels of viral nucleic acid for which cur-
ent vaccines offer no protection and may  be used as a tool for the
urveillance of phylogroup I, II and III Lyssaviruses in a range of hosts
here active infection is suspected. The FAT, whilst very useful and
ble to detect nucleoprotein, it is not as sensitive as the nucleic-acid
etecting hnRT-PCR described by Heaton et al. (1997).  Therefore,
he development of this assay, approximately 200-fold more sen-
itive than the hnRT-PCR, may  allow better estimation of the true
umber of cases of MOKV, DUVV and LBV infection. Further studies
re required to assess the sensitivity and speciﬁcity of this assay,
owever, this assay already may  be useful, where real-time tech-
ology exists. For example, the universal primer pair has already
een used with species speciﬁc probes (Wakeley et al., 2005) for
se in an OIE/WHO reference laboratory.
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